Human Hepatitis B Immunoglobulin IP Vaccine

Trade Name: HepaBsv
Available Strength : 0.5 ML
Available Combination : Hepabsv 100Iu/0.5Ml Inj contains 'hepatitis B immunoglobulin' an antibody extracted from the plasma of the infected donor that acts against the hepatitis B virus (HBV)
Packing : 1X0.5ml
Pack Insert/Leaflet : YES
Therapeutic use : It is used to prevent hepatitis B after exposure to contaminated blood through sexual contact, accidental needle prick injury, from an infected mother to her newborn or after a liver transplant.
Capacity : 1000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.